Livzon Pharmaceutical Group Inc. (1513.HK)
Manufactures pharmaceuticals and drug ingredients for hospitals and reproductive clinics across China and worldwide.
25.98+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-30.7%
The outlook
Livzon Pharmaceutical trades flat today at 25.98, sitting near its 52-week low with mixed momentum against moving averages. Analysts lean bullish with an average price target roughly 32% above current levels, though coverage is modest at four analysts. The stock's trailing P/E of 10.1 suggests relatively low valuation relative to earnings.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Price targetAvg target +32% vs current price
Analyst price target
~12-month · 4 analysts34.17average target+31.5% vs now
Now 25.98
Low 22.08High 46.03
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$23.07B
52-wk high
40.45
52-wk low
23.24
50-day avg
25.93
200-day avg
28.67
Trailing P/E
10.1